Lataa...
Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease
BACKGROUND: Butyrate-producing gut bacteria are reduced in patients with active inflammatory bowel disease (IBD), supporting the hypothesis that butyrate supplementation may be beneficial in this setting. Nonetheless, earlier studies suggest that the oxidation of butyrate in IBD patients is altered....
Tallennettuna:
| Julkaisussa: | Inflamm Bowel Dis |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6905302/ https://ncbi.nlm.nih.gov/pubmed/31211831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izz119 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|